Drug Shortage Report for HP-PAC
Report ID | 32477 |
Drug Identification Number | 02238525 |
Brand name | HP-PAC |
Common or Proper name | LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN |
Company Name | TAKEDA PHARMACEUTICALS AMERICA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN |
Strength(s) | 500MG 30MG 500MG |
Dosage form(s) | KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET |
Route of administration | ORAL |
Packaging size | Blister pack |
ATC code | A02BD |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-05-07 |
Estimated end date | |
Actual end date | 2018-06-25 |
Shortage status | Resolved |
Updated date | 2018-06-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 95 HAYDEN AVENUE LEXINGTON, MASSACHUSETTS UNITED STATES 02421 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.